Charter Trust Co. reduced its holdings in shares of Express Scripts Holding (NASDAQ:ESRX) by 38.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,465 shares of the company’s stock after selling 4,054 shares during the quarter. Charter Trust Co.’s holdings in Express Scripts were worth $483,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Dodge & Cox boosted its stake in shares of Express Scripts by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after acquiring an additional 7,388,021 shares during the period. Macquarie Group Ltd. boosted its stake in shares of Express Scripts by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after acquiring an additional 922,406 shares during the period. Northern Trust Corp boosted its stake in shares of Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after acquiring an additional 1,206,980 shares during the period. Veritas Asset Management LLP boosted its stake in shares of Express Scripts by 5.6% during the 3rd quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock worth $547,902,000 after acquiring an additional 460,338 shares during the period. Finally, Nordea Investment Management AB boosted its stake in shares of Express Scripts by 2.6% during the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock worth $462,551,000 after acquiring an additional 188,528 shares during the period. Institutional investors own 88.21% of the company’s stock.
Several research analysts have recently commented on the company. SunTrust Banks reiterated a “buy” rating and set a $95.00 target price on shares of Express Scripts in a research note on Friday, January 12th. Robert W. Baird reiterated a “buy” rating and set a $92.00 target price (up from $81.00) on shares of Express Scripts in a research note on Tuesday, January 9th. Evercore ISI assumed coverage on Express Scripts in a research note on Thursday, January 4th. They set an “in-line” rating and a $78.00 target price for the company. BidaskClub upgraded Express Scripts from a “buy” rating to a “strong-buy” rating in a research note on Friday, December 22nd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Express Scripts in a research note on Thursday, December 21st. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $77.09.
Shares of Express Scripts Holding (NASDAQ ESRX) opened at $80.78 on Thursday. The firm has a market capitalization of $45,542.05, a P/E ratio of 13.31, a P/E/G ratio of 0.89 and a beta of 0.87. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. Express Scripts Holding has a fifty-two week low of $55.80 and a fifty-two week high of $81.75.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period last year, the firm posted $1.74 EPS. analysts predict that Express Scripts Holding will post 7.04 earnings per share for the current year.
Express Scripts declared that its Board of Directors has authorized a stock buyback plan on Monday, December 18th that authorizes the company to repurchase 45,000,000 shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.
In other Express Scripts news, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the transaction, the vice president now directly owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the acquisition, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Insiders sold a total of 17,644 shares of company stock valued at $1,289,609 over the last ninety days. Insiders own 0.68% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://www.truebluetribune.com/2018/01/18/express-scripts-holding-esrx-shares-sold-by-charter-trust-co.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.